Clinical Trial

FDG PET-CT in Advanced Breast Cancer

Study acronym: PET-000
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 15, 2025 (before its estimated December 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study is a prospective cohort study comparing metabolic response evaluation by F-18 FDG PET-CT versus conventional imaging for outcome stratification in patients with advanced breast cancer receiving first-line systemic therapy.
Trial Details
NCT Number NCT07173868
Lead Sponsor Samsung Medical Center
Conditions Histologically Confirmed Metastatic or Locally Advanced Breast Cancer With no Radical Topical Treatment Available, If There is Liver Metastasis, Which the Researcher Believes Will be Difficult to Evaluate the Response Accurately With Bone Metastasis or CT
Enrollment 100 participants
Start Date 2025-07-25
Primary Completion 2025-12-30 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-09-15